Header image

ES03: Advanced NSCLC: Further Precision Medicine Over Targeted Therapy

Tracks
Saigon 1 Ballroom
Friday, October 10, 2025
10:45 AM - 11:45 AM

Details

This session will invite renowned Asian and international experts on clinical research to comprehensively, precisely present new concepts, cutting-edge knowledge, and significant research findings in NSCLC treatment, including EGFR, ALK, MET, and KRAS, thereby advancing precision medicine over targeted therapy, and maximizing the clinical benefits of NSCLC targeted therapy in Asia. Presentations followed by panel discussion and audience Q&A.


Speaker

Agenda Item Image
Tony Mok
Chinese University Of Hong Kong

Session Chair

10:45 AM - 10:47 AM
Agenda Item Image
Myung-Ju Ahn
Samsung Medical Center

ES03.01: Current Landscape and Future Prospects of EGFR-Targeted Therapy

10:47 AM - 10:59 AM
Agenda Item Image
Makoto Nishio
Cancer Institute Hospital | JFCR

ES03.02: Recent Advances and Future Strategies in ALK/ROS1-Targeted Therapy

10:59 AM - 11:11 AM
Agenda Item Image
Ross Soo
National University Hospital

ES03.03: Challenges and Future Perspectives MET/HER2-Targeted Therapy

11:11 AM - 11:23 AM
Agenda Item Image
Xiuning Le
MD Anderson Cancer Center

ES03.04: Advances in KRAS/RET-Targeted Therapy

11:23 AM - 11:35 AM
loading